These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35068243)

  • 1. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
    Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
    J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs.
    Dubov A; Krakower DS; Rockwood N; Montgomery S; Shoptaw S
    J Gen Intern Med; 2023 Oct; 38(13):2928-2935. PubMed ID: 36964426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
    Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
    Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
    Vincent W; McFarland W
    Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
    Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
    Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
    AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.
    Edelman EJ; Moore BA; Calabrese SK; Berkenblit G; Cunningham C; Patel V; Phillips K; Tetrault JM; Shah M; Fiellin DA; Blackstock O
    AIDS Behav; 2017 Apr; 21(4):1025-1033. PubMed ID: 27896552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
    Mistler CB; Copenhaver MM; Shrestha R
    AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.
    King AR; Shah S; Randall LA; Frew PM; Spaulding A; ; Holloway IW
    BMC Infect Dis; 2022 Sep; 22(1):737. PubMed ID: 36104676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
    Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):449-452. PubMed ID: 36150038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.
    Smith M; Elliott L; Hutchinson SJ; Metcalfe R; Flowers P; McAuley A
    Int J Drug Policy; 2021 Feb; 88():103033. PubMed ID: 33249313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon.
    Spencer HC; Babiarz J; Menza TW
    Int J STD AIDS; 2023 Jul; 34(8):567-573. PubMed ID: 36949570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
    Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
    AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
    Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
    AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
    Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
    Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
    Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
    Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
    Carter G; Meyerson B; Rivers P; Crosby R; Lawrence C; Cope SD; DeBruicker D; Levin S; Meeks W; Thomas C; Turner B; Abert C; Coles H; Allen A; Gonzalez-Fagoaga E; Grivois-Shah R
    AIDS Behav; 2021 Oct; 25(10):3085-3096. PubMed ID: 34003385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.